•Immediately discontinue infus ion of study treatment. •Begin an IV infusion of normal saline and treat the participant as follows: reco mmend bronchodilators, epinephrine 0.2 to 1 mg of a 1:1,000 solution for intramuscular or subcutaneous administration or 0.1 to 0.25 mg of a 1:10,000 solution injected slowly for IV administration, and/or diphenhydramine 50 mg IV with methylprednisolone 100 mg IV (or equivalent), as needed. •Participant should be monitore d until the investigator is comfortable that the symptoms w ill not recur.